Home » Indian Hospira Plant Gets Extensive Form 483
Indian Hospira Plant Gets Extensive Form 483
Sterile injectables maker Hospira was hit with a new Form 483 containing nearly two dozen observations after FDA investigators followed up an October 2012 inspection that uncovered inadequate sanitization procedures at its Irungattukottai, India, facility.
Drug GMP Report
Drugs Inspections and Audits Regulatory AffairsDrug GMP Report
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May